Deng Zhen-Feng, Tang Yan-Jiao, Yan Chun-Yi, Qin Zi-Qian, Yu Ning, Zhong Xiong-Bo
Clinical Genome Center, Guangxi KingMed Diagnostics, Nanning 530007, Guangxi Zhuang Autonomous Region, China.
Graduate School, Guangxi University of Chinese Medicine, Nanning 530001, Guangxi Zhuang Autonomous Region, China.
World J Clin Cases. 2023 Mar 6;11(7):1634-1641. doi: 10.12998/wjcc.v11.i7.1634.
Pulmonary nocardiosis is difficult to diagnose by culture and other conventional testing, and is often associated with lethal disseminated infections. This difficulty poses a great challenge to the timeliness and accuracy of clinical detection, especially in susceptible immunosuppressed individuals. Metagenomic next-generation sequencing (mNGS) has transformed the conventional diagnosis pattern by providing a rapid and precise method to assess all microorganisms in a sample.
A 45-year-old male was hospitalized for cough, chest tightness and fatigue for 3 consecutive days. He had received a kidney transplant 42 d prior to admission. No pathogens were detected at admission. Chest computed tomography showed nodules, streak shadows and fiber lesions in both lung lobes as well as right pleural effusion. Pulmonary tuberculosis with pleural effusion was highly suspected based on the symptoms, imaging and residence in a high tuberculosis-burden area. However, anti-tuberculosis treatment was ineffective, showing no improvement in computed tomography imaging. Pleural effusion and blood samples were subsequently sent for mNGS. The results indicated as the major pathogen. After switching to sulphamethoxazole combined with minocycline for anti-nocardiosis treatment, the patient gradually improved and was finally discharged.
A case of pulmonary nocardiosis with an accompanying bloodstream infection was diagnosed and promptly treated before the dissemination of the infection. This report emphasizes the value of mNGS in the diagnosis of nocardiosis. mNGS may be an effective method for facilitating early diagnosis and prompt treatment in infectious diseases, which overcomes the shortcomings of conventional testing.
肺诺卡菌病通过培养和其他传统检测方法难以诊断,且常与致死性播散性感染相关。这一困难对临床检测的及时性和准确性构成了巨大挑战,尤其是在易感的免疫抑制个体中。宏基因组下一代测序(mNGS)通过提供一种快速且精确的方法来评估样本中的所有微生物,改变了传统的诊断模式。
一名45岁男性因连续3天咳嗽、胸闷和乏力入院。入院前42天接受了肾移植。入院时未检测到病原体。胸部计算机断层扫描显示双肺叶有结节、条索状阴影和纤维病变以及右侧胸腔积液。基于症状、影像学表现以及居住在结核病高负担地区,高度怀疑为结核性胸膜炎伴胸腔积液。然而,抗结核治疗无效,计算机断层扫描影像学无改善。随后将胸腔积液和血液样本送去进行mNGS检测。结果表明 为主要病原体。改用磺胺甲恶唑联合米诺环素进行抗诺卡菌病治疗后,患者逐渐好转,最终出院。
诊断出一例伴有血流感染的肺诺卡菌病病例,并在感染播散前及时进行了治疗。本报告强调了mNGS在诺卡菌病诊断中的价值。mNGS可能是促进传染病早期诊断和及时治疗的有效方法,克服了传统检测的缺点。